Search

Author/Creator Delva, Remy

1. Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial. Issue 7 (July 2015)

Authors:
Fizazi, Karim; Faivre, Laura; Lesaunier, François; Delva, Remy; Gravis, Gwenaëlle; Rolland, Frédéric; Priou, Frank; Ferrero, Jean-Marc; Houede, Nadine; Mourey, Loïc; Theodore, Christine; Krakowski, Ivan; Berdah, Jean-François; Baciuchka, Marjorie; Laguerre, Brigitte; Fléchon, Aude; Ravaud, Alain;...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 7(2015:Jul.)
Page Start:
787
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Clinical benefits of non‐taxane chemotherapies in unselected patients with symptomatic metastatic castration‐resistant prostate cancer after docetaxel: the GETUG‐P02 study. (January 2015)

Authors:
Joly, Florence; Delva, Remy; Mourey, Loïc; Sevin, Emmanuel; Bompas, Emmanuelle; Vedrine, Lionel; Ravaud, Alain; Eymard, Jean‐Christophe; Tubiana‐Mathieu, Nicole; Linassier, Claude; Houede, Nadine; Guillot, Aline; Ringensen, François; Cojocarasu, Oana; Valenza, Bruno; Leconte, Alexandra; Lheureux,...
Journal:
BJU international
Issue:
Volume 115:Number 1(2015:Jan.)
Page Start:
65
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study. Issue 2 (February 2022)

Authors:
Siefker-Radtke, Arlene O; Necchi, Andrea; Park, Se Hoon; García-Donas, Jesús; Huddart, Robert A; Burgess, Earle F; Fleming, Mark T; Rezazadeh Kalebasty, Arash; Mellado, Begoña; Varlamov, Sergei; Joshi, Monika; Duran, Ignacio; Tagawa, Scott T; Zakharia, Yousef; Akapame, Sydney; Santiago-Walker, Ad...
Journal:
Lancet oncology
Issue:
Volume 23:Issue 2(2022)
Page Start:
248
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Long survival of patients with metastatic clear cell renal cell carcinoma. Results of real life study of 344 patients. Issue 6 (1st August 2019)

Authors:
Voog, Eric; Campillo‐Gimenez, Boris; Elkouri, Claude; Priou, Franck; Rolland, Frederic; Laguerre, Brigitte; Elhannani, Chaza; Merrer, Jacques; Pfister, Christian; Sevin, Emmanuel; L'Haridon, Tifenn; Hasbini, Ali; Moise, Laura; Le Rol, Annick; Malhaire, Jean Pierre; Delva, Remy; Vauléon, Elodie; C...
Journal:
International journal of cancer
Issue:
Volume 146:Issue 6(2020)
Page Start:
1643
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Unexpected response to cisplatin rechallenge after immune checkpoint inhibitors in patients with metastatic urothelial carcinoma refractory to platinum regimen. (November 2018)

Authors:
Gravis, Gwenaëlle; Billon, Emilien; Baldini, Capucine; Massard, Christophe; Hilgers, Werner; Delva, Remy; Walz, Jochen; Pignot, Geraldine; Rybikowski, Stanislas; Dermeche, Slimane; Thomassin, Jeanne; Brunelle, Serge; Lavaud, Pernelle; Loriot, Yohann
Journal:
European journal of cancer
Issue:
Volume 104(2018)
Page Start:
236
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗